Ontology highlight
ABSTRACT:
SUBMITTER: La Rosa S
PROVIDER: S-EPMC6949486 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
La Rosa Salvatore S Browder Vidya V Bakker Annette C AC Blakeley Jaishri O JO Verma Sharad K SK Wong Ling M LM Morris Jill J Bora Naba N
EMBO molecular medicine 20191202 1
The time from identifying a drug target to a new drug approval is often measured in decades and can take even longer for therapies to treat rare diseases. In fact, 95% of rare diseases do not have a specific therapy approved at all. Coordinated efforts to augment the drug development pipeline along with long-term and comprehensive support that enable scientific breakthroughs for rare diseases are possible, but it requires integration across multiple stakeholders. This article analyzes the coordi ...[more]